Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Gentile, Ivan ^a   Talamo, Maria ^a   Borgia, Guglielmo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; AZITHROMYCIN; BETAMETHASONE; CEFIXIME; CORTICOSTEROID; ESCITALOPRAM; FENOXIFENADINE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; LAMOTRIGINE; PREDNISONE; PROTON PUMP INHIBITOR; STEROID; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; IMMUNOLOGIC FACTOR; VIRUS ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; AUTOIMMUNE DISEASE; BIPOLAR DISORDER; BREAST RECONSTRUCTION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; DENDRITIC CELL; DIFFERENTIAL DIAGNOSIS; DRESS SYNDROME; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; FEVER; HEPATITIS; HEPATOMEGALY; HERPES VIRUS INFECTION; HUMAN; IMMUNE SYSTEM; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MACULOPAPULAR RASH; MYALGIA; NAUSEA; PATHOGENESIS; PYREXIA IDIOPATHICA; T LYMPHOCYTE; VASCULITIS; VIRUS REACTIVATION; VON WILLEBRAND DISEASE; EXANTHEMA SUBITUM; HUMAN HERPESVIRUS 6; HYPERSENSITIVITY; IMMUNOLOGY; ISOLATION AND PURIFICATION; REVIEW; TREATMENT OUTCOME;

ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; HYPERSENSITIVITY; IMMUNOLOGIC FACTORS; PREDNISONE; ROSEOLOVIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 77952317247     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-49     Document Type: Article

References (33)

1. Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol 2007, 33:124-133. 10.1007/s12016-007-8010-9, 18094951.
2. Calabrese JR, Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, Shelton MD, Goodwin FK, Frye MA, Kusumakar V. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 2002, 63:1012-1019.
3. Seitz CS, Pfeuffer P, Raith P, Bröcker EB, Trautmann A. Anticonvulsant hypersensitivity syndrome: cross-reactivity with tricyclic antidepressant agents. Ann Allergy Asthma Immunol 2006, 97:698-702. 10.1016/S1081-1206(10)61103-9, 17165282.
4. Bohan KH, Mansuri TF, Wilson NM. Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care. Pharmacotherapy 2007, 27:1425-1439. 10.1592/phco.27.10.1425, 17896897.
5. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest 1988, 82:1826-1832. 10.1172/JCI113798, 442760, 3198757.
6. Moss DM, Rudis M, Henderson SO. Cross-sensitivity and the anticonvulsant hypersensitivity syndrome. J Emerg Med 1999, 17:503-506. 10.1016/S0736-4679(99)00042-6, 10338246.
7. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Spielberg SP. Familial occurrence of hypersensitivity to phenytoin. Am J Med 1991, 91:631-634. 10.1016/0002-9343(91)90216-K, 1750433.
8. Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol 1998, 134:1108-1112. 10.1001/archderm.134.9.1108, 9762023.
9. Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. Br J Dermatol 2006, 155:344-349. 10.1111/j.1365-2133.2006.07332.x, 16882173.
10. Descamps V, Mahe E, Houhou N, Abramowitz L, Rozenberg F, Rnager-Rogez S, Crickx B. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol 2003, 148:1032-1034. 10.1046/j.1365-2133.2003.05330.x, 12786838.
11. Aihara M, Sugita Y, Takahashi S, Nagatani T, Arata S, Takeuchi K, Ikezawa Z. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001, 144:1231-1234. 10.1046/j.1365-2133.2001.04239.x, 11422048.
12. Shiohara T, Kano Y. Are viral infections responsible for the development of drug-induced hypersensitivity syndrome as well as graft-versus-host diseases?. Dermatology 2005, 210:259-260. 10.1159/000084747, 15942209.
13. Kano Y, Hirahara K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multi-organ reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006, 155:301-306. 10.1111/j.1365-2133.2006.07238.x, 16882166.
14. Straus SE. Human Herpesvirus types 6 and 7. Principles and Practice of Infectious Diseases 2005, 1821-1825. Philadelphia: Churchill Livingstone, Mandell GL, Bennett JE, Dolin R.
15. Hall CB, Caserta MT, Schnabel K, Shelley LM, Marino AS, Carnahan JA, Yoo C, Lofthus GK, McDermott MP. Chromosomal integration of human herpesvirus 6 is the major mode of congenital human herpesvirus 6 infection. Pediatrics 2008, 122:513-520. 10.1542/peds.2007-2838, 18762520.
16. Watanabe H, Daibata M, Tohyama M, Batchelor J, Hashimoto K, Iijima M. Chromosomal integration of human herpesvirus 6 DNA in anticonvulsant hypersensitivity syndrome. Br J Dermatol 2008, 158:640-642. 10.1111/j.1365-2133.2007.08382.x, 18076699.
17. Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, Berry N, Stachulski AV, Clarke SE, Pichler WJ, Pirmohamed M, Park BK, Naisbitt DJ. Activation of T cells by carbamazepine and its metabolites. J Allergy Clin Immunol 2006, 118:233-234. 10.1016/j.jaci.2006.03.005, 16815161.
18. Katsafanas GC, Schirmer EC, Wyatt LS, Frenkel N. In vitro activation of human herpesviruses 6 and 7 from latency. Proc Natl Acad Sci USA 1996, 93:9788-9792. 10.1073/pnas.93.18.9788, 38507, 8790409.
19. Aihara Y, Ito SI, Kobayashi Y, Yamakawa Y, Aihara M, Yokota S. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol 2003, 149:165-169. 10.1046/j.1365-2133.2003.05368.x, 12890212.
20. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol 2004, 140:183-188. 10.1001/archderm.140.2.183, 14967790.
21. Shiohara T, Takahashi R, Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. Drug Hypersensitivity 2007, 224-239. Basel: Karger, Picher WY.
22. Yoshikawa T, Fujita A, Yagami A, Suzuki K, Matsunaga K, Ihira M, Asano Y. Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome. J Clin Virol 2006, 37(Suppl 1):S92-S96. 10.1016/S1386-6532(06)70019-1, 17276377.
23. Alldredge BK, Knutsen AP, Ferriero D. Antiepileptic drug hypersensitivity syndrome: in vitro and clinical observations. Pediatr Neurol 1994, 10:169-171. 10.1016/0887-8994(94)90054-X, 8024670.
24. Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol 2006, 54(2 Suppl):S14-S17. 10.1016/j.jaad.2005.03.057, 16427984.
25. Sakuma K, Kano Y, Fukuhara M, Shiohara T. Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome. Clin Exp Dermatol 2008, 33:287-290. 10.1111/j.1365-2230.2007.02645.x, 18201256.
26. Korem M, Hiller N, Ackerman Z, Chajek-Shaul T, Abramowitz Y. Spleen rupture secondary to anticonvulsant hypersensitivity syndrome. Eur J Intern Med 2006, 17:517-519. 10.1016/j.ejim.2006.04.005, 17098601.
27. Atkinson RJ, Dennis G, Cross SS, McAlindon ME, Sharrack B, Sanders DS. Eosinophilic colitis complicating anti-epileptic hypersensitivity syndrome: an indication for colonoscopy?. Gastrointest Endosc 2004, 60:1034-1036. 10.1016/S0016-5107(04)02233-3, 15605034.
28. Balatsinou C, Milano A, Caldarella MP, Laterza F, Pierdomenico SD, Cuccurullo F, Neri M. Eosinophilic esophagitis is a component of the anticonvulsant hypersensitivity syndrome: description of two cases. Dig Liver Dis 2008, 40:145-148. 10.1016/j.dld.2007.01.017, 17395557.
29. Zaidi AN. Anticonvulsant hypersensitivity syndrome leading to reversible myocarditis. Can J Clin Pharmacol 2005, 12:e33-e40.
30. Asano Y, Kagawa H, Kano Y, Shiohara T. Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome. Arch Dermatol 2009, 145:1030-1036. 10.1001/archdermatol.2009.195, 19770444.
31. Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and anti-drug immune responses. Allergol Int 2006, 55:1-8. 10.2332/allergolint.55.1, 17075280.
32. Cumbo-Nacheli G, Weinberger J, Alkhalil M, Thati N, Baptist AP. Anticonvulsant hypersensitivity syndrome: is there a role for immunomodulation?. Epilepsia 2008, 49:2108-2112. 10.1111/j.1528-1167.2008.01720.x, 18637830.
33. Kano Y, Inaoka M, Sakuma K, Shiohara T. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology 2005, 209:165-167. 10.1016/j.tox.2004.12.013, 15767030.